ADMA Biologics, Inc. (ADMA)
8.05
-0.10
(-1.23%)
USD |
NASDAQ |
May 27, 13:06
ADMA Biologics Free Cash Flow : 107.55M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| Inovio Pharmaceuticals, Inc. | -83.57M |
| Palisade Bio, Inc. | -12.40M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| AnaptysBio, Inc. | 4.409M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 58.25M |
| Cash from Investing (Quarterly) | 2.404M |
| Cash from Financing (Quarterly) | -10.13M |
| Free Cash Flow Per Share (Quarterly) | 0.2319 |
| Free Cash Flow to Equity (Quarterly) | -68.87M |
| Free Cash Flow to Firm (Quarterly) | 57.32M |
| Free Cash Flow Yield | 5.47% |